SIHUAN PHARM (00460.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec8

Sinopharm's Pyrolacitib Inclusion in National Health Insurance Directory for the First Time

08:46

Oct30

ChinaRx Pharmaceuticals and AbaloneBio Sign Cooperation Agreement to Jointly Develop Next-Generation Obesity Treatment Drugs

00:13

Oct26

Four Ring Medical Completed Acquisition and Subsidiary IPO with Breakthrough

04:17

Oct17

PharmaChina International Repurchased 15 Million Shares

13:02

Oct15

Sinopharm Central Asia Repurchased 10 Million Shares

11:15

Oct13

Sinopharm Four Ring invests in Suisselle to deepen global aesthetic market layout

00:02

Schedules & Filings

Schedules

Filings

Oct14

Distribution Plan(CST)

Right issue 1 for every 2.728 K shrs held

Oct10

Distribution Plan(CST)

Cash dividend 0.0109 HKD

Sep29

Distribution Plan(CST)

Cash dividend 0.0109 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More